CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obéid, Antoine Tesnière, François Ghiringhelli et al. · Nature Medicine · 2006 · 3.1K citations

Medicine, Immunology, Oncology +14

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan et al. · New England Journal of Medicine · 2013 · 2K citations · Full text

Medicine, Genetics, Hematology +14

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>

Jyoti Nangalia, Charles Massie, E. Joanna Baxter et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Medicine, Genetics, Molecular Genetics +15

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

Naseema Gangat, Domenica Caramazza, Rakhee Vaidya et al. · Journal of Clinical Oncology · 2010 · 1K citations · Full text

Medicine, Hematology, Clinical Classification Systems +16

Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death

Theocharis Panaretakis, Oliver Kepp, Ulf Brockmeier et al. · The EMBO Journal · 2009 · 826 citations · Full text

Life Sciences, Cell Biology, Immunology +11